Logenex Pharm
Logenex Pharm, headquartered in Germany, is a prominent player in the pharmaceutical industry, specialising in innovative healthcare solutions. Founded in 2010, the company has rapidly expanded its operational footprint across Europe, focusing on the development and distribution of high-quality pharmaceutical products. With a commitment to excellence, Logenex Pharm offers a diverse range of services, including drug development, regulatory affairs, and market access strategies. Their unique approach combines cutting-edge technology with a deep understanding of market needs, positioning them as a trusted partner in the healthcare sector. Recognised for their contributions to patient care, Logenex Pharm has achieved significant milestones, including successful product launches and strategic collaborations. Their dedication to quality and innovation continues to solidify their reputation as a leader in the pharmaceutical landscape.
DitchCarbon Score
How does Logenex Pharm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Logenex Pharm's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Logenex Pharm's reported carbon emissions
Logenex Pharm, headquartered in Germany (DE), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Logenex Pharm has not outlined any specific reduction targets or initiatives related to carbon emissions. Additionally, there are no commitments to the Science Based Targets initiative (SBTi) or any climate pledges mentioned. As the pharmaceutical industry increasingly focuses on sustainability and climate action, Logenex Pharm's future commitments and strategies will be crucial in addressing their environmental impact and aligning with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Logenex Pharm is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
